The inflammasome behaves differently during disease progression; normally, NLRP3 is minimally expressed, but inflammatory bowel disease triggers increased cellular permeability and intestinal mucosa damage, activating the inflammasome. The gene discussed is NLRP3; the disease is inflammatory bowel disease.